RAYMOND JAMES & ASSOCIATES - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 131 filers reported holding FLEXION THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,713,000
-9.5%
444,705
+22.1%
0.00%
-33.3%
Q2 2021$2,997,000
+67.8%
364,176
+82.5%
0.00%
+50.0%
Q1 2021$1,786,000
-22.0%
199,581
+0.6%
0.00%
-33.3%
Q4 2020$2,289,000
+1.2%
198,373
-8.7%
0.00%0.0%
Q3 2020$2,262,000
-22.7%
217,327
-2.3%
0.00%
-25.0%
Q2 2020$2,926,000
+57.5%
222,546
-5.7%
0.00%
+33.3%
Q1 2020$1,858,000
-37.7%
236,054
+63.7%
0.00%
-25.0%
Q4 2019$2,984,000
+27.2%
144,177
-15.8%
0.00%
+33.3%
Q3 2019$2,346,000
-13.7%
171,167
-22.5%
0.00%
-25.0%
Q2 2019$2,717,000
+9.0%
220,899
+10.6%
0.00%0.0%
Q1 2019$2,492,000
+60.4%
199,715
+45.4%
0.00%
+33.3%
Q4 2018$1,554,000
-55.8%
137,316
-27.0%
0.00%
-40.0%
Q3 2018$3,518,000
-19.1%
188,003
+11.8%
0.01%
-28.6%
Q2 2018$4,346,000
-4.4%
168,115
-26.1%
0.01%
-12.5%
Q1 2018$4,546,000
-13.5%
227,441
-0.2%
0.01%
-20.0%
Q4 2017$5,253,000
+75.0%
228,000
+83.7%
0.01%
+66.7%
Q3 2017$3,001,000
+23.4%
124,128
+3.2%
0.01%
+20.0%
Q2 2017$2,431,000
+28.2%
120,245
+34.9%
0.01%
+25.0%
Q1 2017$1,896,000
+386.2%
89,110
+334.7%
0.00%
+300.0%
Q4 2016$390,00020,5000.00%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Novo Holdings A/S 1,500,000$36,270,0004.72%
Gagnon Advisors, LLC 108,498$2,623,0001.99%
NEXTHERA CAPITAL LP 271,136$6,556,0001.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 883,321$21,359,0001.39%
GILDER GAGNON HOWE & CO LLC 3,961,647$95,793,0001.35%
GAGNON SECURITIES LLC 144,331$3,490,0001.30%
MILLER VALUE PARTNERS, LLC 1,181,325$28,564,0001.23%
SCHOLTZ & COMPANY, LLC 55,250$1,336,0001.05%
ARDSLEY ADVISORY PARTNERS LP 175,000$4,232,0000.56%
Ratan Capital Management LP 32,077$776,0000.47%
View complete list of FLEXION THERAPEUTICS INC shareholders